Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: A randomized trial

JAMA

Volumn 306, Issue 2, 2011, Pages 163-171

  Wainwright, Claire E ^a   Vidmar, Suzanna ^b,c   Armstrong, David S ^d   Byrnes, Catherine A ^e,f   Carlin, John B ^b,c   Cheney, Joyce ^a   Cooper, Peter J ^g   Grimwood, Keith ^a   Moodie, Marj ^h   Robertson, Colin F ^b   Tiddens, Harm A ^i,j  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

^f STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^g CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^h DEAKIN UNIVERSITY   (Australia)

ⁱ SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^j ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRONCHOALVEOLAR LAVAGE DIRECTED THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; INFANT; LUNG INJURY; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN SCREENING; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 79960151730     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.954     Document Type: Article

References (40)

1. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003;168(8):918-951. (Pubitemid 37267172)
2. Rosenfeld M, Emerson J, Accurso F, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol. 1999;28(5):321-328. (Pubitemid 29523443)
3. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Olinsky A, Phelan PD. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol. 1996;21(5):267-275. (Pubitemid 26159822)
4. Paul K, Rietschel E, Ballmann M, et al; Bronchoalveolar Lavage for the Evaluation of Antiinflammatory Treatment Study Group. Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis. Am J Respir Crit Care Med. 2004;169(6):719-725. (Pubitemid 38338924)
5. Sly PD, Brennan S, Gangell C, et al; Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST-CF). Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med. 2009;180(2):146-152.
6. Hilliard TN, Sukhani S, Francis J, et al. Bronchoscopy following diagnosis with cystic fibrosis. Arch Dis Child. 2007;92(10):898-899. (Pubitemid 47535453)
7. Wainwright CE, Grimwood K, Carlin JB, et al. Safety of bronchoalveolar lavage in young children with cystic fibrosis. Pediatr Pulmonol. 2008;43(10):965-972.
8. Nixon GM, Armstrong DS, Carzino R, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr. 2001;138(5):699-704. (Pubitemid 32417671)
9. Cystic Fibrosis Foundation. Patient Registry Annual Data Report 2008. Bethesda, MD: Cystic Fibrosis Foundation; 2009.
10. Treggiari MM, Rosenfeld M, Retsch-Bogart G, Gibson R, Ramsey B. Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis. Pediatr Pulmonol. 2007;42(9):751-756. (Pubitemid 47580800)
11. Ratjen F, Munck A, Kho P, Angyalosi G; ELITE Study Group. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax. 2010;65(4):286-291.
12. Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003;2(1):29-34. (Pubitemid 36857407)
13. Li Z, Kosorok MR, Farrell PM, et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in childrenwith cystic fibrosis. JAMA. 2005;293(5):581-588. (Pubitemid 40171240)
14. Southern KW, Peckham D. Establishing a diagnosis of cystic fibrosis. Chron Respir Dis. 2004;1(4):205-210.
15. Bell S, Robinson P. Cystic Fibrosis Standards of Care, Australia. Sydney: Cystic Fibrosis Australia; 2008.
16. Wesley AW, Asher MI, Gillies JD, Pattemore PK, Kerr A, Hewitt C. Proposals for standards of cystic fibrosis management in New Zealand: a position statement by the Respiratory Committee of the Paediatric Society of New Zealand. N Z Med J. 1996;109(1020):140-141. (Pubitemid 126523796)
17. Schmid J, Ling LJ, Leung JL, et al. Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics. Eur Respir J. 2008;32(6):1583-1590.
18. Armstrong DS, Hook SM, Jamsen KM, et al. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol. 2005;40(6):500-510. (Pubitemid 41720706)
19. Brody AS, Klein JS, Molina PL, Quan J, Bean JA, Wilmott RW. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr. 2004;145(1):32-38. (Pubitemid 38962449)
20. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152(3):1107-1136.
21. de Jong PA, Nakano Y, Lequin MH, et al. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J. 2004;23(1):93-97. (Pubitemid 38088503)
22. Schulz KF, Grimes DA. Multiplicity in randomised trials I: endpoints and treatments. Lancet. 2005;365(9470):1591-1595. (Pubitemid 40615409)
23. Lee TW. Eradication of early Pseudomonas infection in cystic fibrosis. Chron Respir Dis. 2009;6(2):99-107.
24. Lebecque P, Leal T, Zylberberg K, Reychler G, Bossuyt X, Godding V. Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis. J Cyst Fibros. 2006;5(4):237-244. (Pubitemid 44824859)
25. Lee TW, Brownlee KG, Denton M, Littlewood JM, Conway SP. Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center. Pediatr Pulmonol. 2004;37(2):104-110. (Pubitemid 38120979)
26. Lillquist YP, Cho E, Davidson AG. Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009. J Cyst Fibros. 2011;10(3):175-180.
27. Stick SM, Brennan S, Murray C, et al; Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF). Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr. 2009;155(5):623-628.
28. Tiddens HA, Donaldson SH, Rosenfeld M, Paré PD. Cystic fibrosis lung disease starts in the small airways: canwetreat it more effectively? Pediatr Pulmonol. 2010;45(2):107-117.
29. Crowley S, Matthews I. Resolution of extensive severe bronchiectasis in an infant. Pediatr Pulmonol. 2010;45(7):717-720.
30. Gaillard EA, Carty H, Heaf D, Smyth RL. Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. Eur J Radiol. 2003;47(3):215-220. (Pubitemid 36970082)
31. Robinson TE, Goris ML, Zhu HJ, et al. Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysis. Chest. 2005;128(4):2327-2335. (Pubitemid 41507576)
32. Tiddens HA, de Jong PA. Update on the application of chest computed tomography scanning to cystic fibrosis. Curr Opin Pulm Med. 2006;12(6):433-439. (Pubitemid 44624604)
33. Brody AS, Tiddens HA, Castile RG, et al; CT Scanning in Cystic Fibrosis Special Interest Group. Computed tomography in the evaluation of cystic fibrosis lung disease. Am J Respir Crit Care Med. 2005;172(10):1246-1252. (Pubitemid 43076562)
34. Loeve M, Gerbrands K, Hop WC, Rosenfeld M, Hartmann IC, Tiddens HA. Bronchiectasis and pulmonary exacerbations in children and young adults with CF [published online ahead of print December 9, 2010]. Chest. 2010. doi:10.1378/chest.10-1152.
35. Tiddens HA. Detecting early structural lung damage in cystic fibrosis. Pediatr Pulmonol. 2002;34(3):228-231. (Pubitemid 34971078)
36. Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001;176(2):289-296. (Pubitemid 32105628)
37. Linnane B, Robinson P, Ranganathan S, Stick S, Murray C. Role of high-resolution computed tomography in the detection of early cystic fibrosis lung disease. Paediatr Respir Rev. 2008;9(3):168-174.
38. Fortier MA, Del Rosario AM, Martin SR, Kain ZN. Perioperative anxiety in children. Paediatr Anaesth. 2010;20(4):318-322.
39. Armstrong DS, Nixon GM, Carzino R, et al. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med. 2002;166(7):983-987. (Pubitemid 35193230)
40. Grimwood K, Kidd TJ, Tweed M. Successful treatment of cepacia syndrome. J Cyst Fibros. 2009;8(4):291-293.